Phase 1 trial of entinostat as monotherapy and combined with exemestane in Japanese patients with hormone receptor-positive advanced breast cancer.

Norikazu MasudaKenji TamuraHiroyuki YasojimaAkihiko ShimomuraMasataka SawakiMin-Jung LeeAkira YunoJane TrepelRyoko KimuraYozo NishimuraShigehira SajiHiroji Iwata

Published in: BMC cancer (2021)

JAPIC Clinical Trial Information, JapicCTI-153066 . Registered 12 November 2015. ClinicalTrials.gov, NCT02623751 . Registered 8 December 2015.

Keyphrases

clinical trial
open label
combination therapy
phase ii
study protocol
metastatic breast cancer
health information
double blind
phase iii
randomized controlled trial
breast cancer risk